Patients for whom HOLTER ECG monitoring is clinically indicated, to early identify the possible onset or progression of diabetic autonomic neuropathy, or ischemic changes, or potentially arrhythmogenic electrophysiological alterations;
On optimized pharmacological treatment according to clinical practice, naïve to SGLT2 inhibitor therapy, prescribed according to the (1A) recommendations of the ESC 2023 guidelines.
You may not be if
Patients with atrial fibrillation or other arrhythmic burden incompatible with accurate HRV analysis;
Pacemaker or ICD carriers;
Immunodeficient patients or patients at risk of developing infections.
Clareo Health | Monitoring of the Sympathetic/Vagal Balance Through Multiparametric Analysis of Heart Rate Variability (HRV)
